Author: Ryan Holtz

Ryan Holtz is a Senior Editor at Tech Insider covering Technology & Services sector stocks. His coverage universe includes Chinese Internet stocks in the eCommerce and online video sectors, Chinese online games stocks, as well as education companies. Holtz previously lived in Hong Kong for four years where he served in a dual role as head of Piper Jaffray Asia equity research and senior research analyst covering Chinese stocks. Before joining TI, Ryan was a management consultant at Deloitte & Touche LLC, where he worked in the financial services group.
Services Sector

Services Sector Weeks 20% Losers: China Distance Education (NYSE:DL), CHC (NYSE:HELI), Bridgepoint Education (NYSE:BPI), China Lodging Group (NASDAQ:HTHT)

China Distance Education Holdings Limited (NYSE:DL) (“CDEL”, or the “Company”), a leading provider of online education in China focusing on professional education, today announced that the follow-on public offering of an aggregate of 4,000,000 American Depositary Shares (“ADSs”) by the Company and several selling shareholders was priced at US$21.00 per ADS. China Distance Education Hldgs Ltd (ADR) (NYSE:DL) stock performance was -1.84% in last session … Continue reading Services Sector Weeks 20% Losers: China Distance Education (NYSE:DL), CHC (NYSE:HELI), Bridgepoint Education (NYSE:BPI), China Lodging Group (NASDAQ:HTHT)

Ryan Holtz
BioTech

Is InterMune (NASDAQ:ITMN) a Takeover Candidate?

InterMune (NASDAQ:ITMN) March 34 and 35 calls are active on total call volume 3,100 contracts (500 puts) on attracting takeover interest, Reuters says. March call option implied volatility is at 90, April is at 88, May and July is at 82; compared to its 26-week average of 90 according to Track Data. Active call volume suggests traders taking positions for price movement, according to theflyonthewall.com. … Continue reading Is InterMune (NASDAQ:ITMN) a Takeover Candidate?

Ryan Holtz
BioTech

Peregrine Pharmaceuticals (NASDAQ:PPHM) Up 20% to 19-Month High; Agenus (NASDAQ:AGEN) Soars

Peregrine Pharmaceuticals (NASDAQ:PPHM) is up nearly 20% and reached a 19-month high after the biopharmaceutical company said Wednesday that it will present data from three preclinical studies highlighting the immuno-oncology and anti-viral potential of phosphatidylserine (PS)-targeting antibodies. Results will be presented at two upcoming Keystone Symposia to be held March 9-13. Shares of Peregrine (NASDAQ:PPHM) are at $2.29, and earlier touched $2.37 – its highest price … Continue reading Peregrine Pharmaceuticals (NASDAQ:PPHM) Up 20% to 19-Month High; Agenus (NASDAQ:AGEN) Soars

Ryan Holtz
Finance, Internet, Mobile

Tech Runners: Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK), Tesla Motors Inc (NASDAQ:TSLA), BlackBerry Ltd (NASDAQ:BBRY)

Apple Inc. (NASDAQ:AAPL) is hiring hundreds of new engineers and supply-chain managers in China and Taiwan as it attempts to speed product development and introduce a wider range of devices. Apple Inc. (NASDAQ:AAPL) stock performance was 0.29% in last session and finished the day at $527.76. Traded volume was 8,516,392 million shares in the last session and the average volume of the stock remained 12.69 … Continue reading Tech Runners: Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK), Tesla Motors Inc (NASDAQ:TSLA), BlackBerry Ltd (NASDAQ:BBRY)

Ryan Holtz
BioTech, Services Sector, Venture Capital

St. Jude Announces Consistent Q3 Results

St. Jude Medical released third-quarter performance that was generally consistent with our expectations, and we have not altered our projections for the full year.  However, we plan to modestly raise our fair value estimate to reflect the reduced share count and cash flow realized since our last update. While St. Jude continues to wrestle with a lackluster implantable cardioverter defibrillator market, we still think the … Continue reading St. Jude Announces Consistent Q3 Results

Ryan HoltzLeave a comment
Analysis, Finance

ATMI Posts Disappointing Earnings; Revenue Drops to $100.2 Million

ATMI reported third-quarter results that were slightly below our expectations due to near-term softness in manufacturing activity in the chip industry. We are maintaining our fair value estimate and moat rating. For the quarter, revenue was $100.2 million, down 2% sequentially and down from sales of $109 million in the year-ago quarter. A near-term slowdown in semiconductor industry manufacturing activity affected demand for ATMI’s products, … Continue reading ATMI Posts Disappointing Earnings; Revenue Drops to $100.2 Million

Ryan HoltzLeave a comment